Search companies or stocks...
ITRMIterum Therapeutics plc
At close · 31 Mar 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is…
Current stock price of Iterum Therapeutics plc (ITRM) stock is $0.030. The stock price is -10.98% lower in the session. The intraday range can be seen from this page. Volume of Iterum Therapeutics plc (ITRM) stock is 49.30M.
Last updated at 31 Mar 2026, 08:00 pm.
The stock price of Iterum Therapeutics plc (ITRM) can change with earnings, company news, and overall market sentiment. Iterum Therapeutics plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Iterum Therapeutics plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ITRM on this page is -0.04. EPS on this page is -0.72. Compare those figures with peers and growth expectations before deciding if the current Iterum Therapeutics plc price is justified.
Historical performance for Iterum Therapeutics plc (ITRM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ITRM reacted to past earnings and market events.
Buying Iterum Therapeutics plc (ITRM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
